Literature DB >> 2229345

Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species.

D M Citron1, E J Baron, S M Finegold, E J Goldstein.   

Abstract

The rapid identification of isolates of bile-resistant Bacteroides species has clinical and therapeutic relevance because of differences in their patterns of susceptibility and virulence. Five hundred twenty-one strains of bile-resistant Bacteroides species that were previously identified by conventional biochemical methods were reexamined to determine the minimum essential parameters necessary for correct identification. Rapid tests for bile resistance, indole production, and catalase were combined with a novel scheme for biochemical determination of saccharolytic activity on arabinose, trehalose, rhamnose, and/or xylan that included the postincubation addition of bromthymol blue for visual pH determination. Organisms were inoculated into prereduced anaerobically sterilized (PRAS) carbohydrates directly from plates, and identification was complete within 24 h of obtaining a pure culture. Ninety-three percent of bile-resistant Bacteroides species from routine clinical specimens were identified correctly by this scheme; a small number of other indole-positive strains, B. splanchnicus, B. eggerthii, and B. stercoris, were misidentified as B. uniformis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229345      PMCID: PMC268151          DOI: 10.1128/jcm.28.10.2220-2223.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.

Authors:  D L Kasper
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

2.  Bacteroidaceae bacteremia: clinical experience with 112 patients.

Authors:  A W Chow; L B Guze
Journal:  Medicine (Baltimore)       Date:  1974-03       Impact factor: 1.889

3.  Comparison of RapID-ANA and Minitek with a conventional method for biochemical identification of anaerobes.

Authors:  Z Hussain; R Lannigan; B C Schieven; L Stoakes; T Kelly; D Groves
Journal:  Diagn Microbiol Infect Dis       Date:  1987-05       Impact factor: 2.803

4.  Clinical evaluation of the Vitek ANI card for identification of anaerobic bacteria.

Authors:  P C Schreckenberger; D M Celig; W M Janda
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

5.  Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon.

Authors:  A A Salyers; J R Vercellotti; S E West; T D Wilkins
Journal:  Appl Environ Microbiol       Date:  1977-02       Impact factor: 4.792

6.  Anaerobic bacterial bacteremia: 12-year experience in two military hospitals.

Authors:  I Brook
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

7.  Comparative evaluation of three identification systems for anaerobes.

Authors:  P R Murray; C J Weber; A C Niles
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

8.  Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.

Authors:  E J Goldstein; D M Citron
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

9.  Six-year retrospective survey of the resistance of Bacteroides fragilis group species to clindamycin and cefoxitin.

Authors:  H M Wexler; B Harris; W T Carter; S M Finegold
Journal:  Diagn Microbiol Infect Dis       Date:  1986-03       Impact factor: 2.803

10.  Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation.

Authors:  G J Cuchural; F P Tally; N V Jacobus; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe; C Pierson
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

View more
  8 in total

Review 1.  A primer on anaerobic bacteria and anaerobic infections for the uninitiated.

Authors:  I Olsen; C O Solberg; S M Finegold
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

2.  PCR-enzyme-linked immunosorbent assay and partial rRNA gene sequencing: a rational approach to identifying mycobacteria.

Authors:  S Patel; M Yates; N A Saunders
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  National hospital survey of anaerobic culture and susceptibility testing methods: results and recommendations for improvement.

Authors:  E J Goldstein; D M Citron; R J Goldman
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

4.  Evaluation of 16S rRNA sequencing and reevaluation of a short biochemical scheme for identification of clinically significant Bacteroides species.

Authors:  Yuli Song; Chengxu Liu; Mauricio Bolanos; Julia Lee; Maureen McTeague; Sydney M Finegold
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Survival of anaerobic bacteria in various thioglycolate and chopped meat broth formulations.

Authors:  M C Claros; D M Citron; E J Goldstein
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group.

Authors:  E J Goldstein; D M Citron; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

7.  Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

8.  Bacteroides ovatus Promotes IL-22 Production and Reduces Trinitrobenzene Sulfonic Acid-Driven Colonic Inflammation.

Authors:  Faith D Ihekweazu; Melinda A Engevik; Wenly Ruan; Zhongcheng Shi; Robert Fultz; Kristen A Engevik; Alexandra L Chang-Graham; Jasmin Freeborn; Evelyn S Park; Susan Venable; Thomas D Horvath; Sigmund J Haidacher; Anthony M Haag; Annie Goodwin; Deborah A Schady; Joseph M Hyser; Jennifer K Spinler; Yuying Liu; James Versalovic
Journal:  Am J Pathol       Date:  2021-01-28       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.